Condition: Thymus Epithelial Tumor · Proton Radiotherapy · Radiation Toxicity · Sponsor: Jian Chen
To observe the efficacy and toxicities of post-operative (R0/R1) proton radiotherapy for locally advanced primary thymus epithelial malignancies. The primary endpoint was progression-free survival and toxicities, and the secondary endpoint was overall survival and cause-specific survival.
This description comes directly from the study's public registry record.
Jing Li · 86-21-38296678 · jing.li@sphic.org.cn
Kun Liu · 86-21-38296678 · kun.liu@sphic.org.cn
Always discuss trial participation with your own doctor first.
| Shanghai Proton and Heavy Ion Center | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06311968